Genetically-Related Cord Blood Stem Cells Do Better in Patient Transplants

by Steven Ertelt, LifeNews.com Editor

Atlanta, GA (LifeNews.com) -- New research presented today at the American Society of Hematology annual meeting shows that using genetically-related cord blood stem cells in transplants increases the chance of success. The study reinforces the idea of parents storing their baby's umbilical cords and blood for use in potential therapies...

Read more

GVHD BBC

An explanation as to why cord blood containing so many stem cells in this interesting short clip from BBC show Life Blood & why it is less likely to cause rejection. BBC

Read more

Haematopoietic stem cell transplantation for autoimmune diseases

Joost F. Swart, Eveline M. Delemarre, Femke van Wijk, Jaap-Jan Boelens, Jürgen Kuball, Jacob M. van Laar, Nico M. Wulffraat

Nature Reviews Rheumatology, 13, 244–256, (2017)

Autologous haematopoietic stem cell transplantation (HSCT) is the only treatment that is able to induce long-term, drug-free and symptom-free remission in several refractory autoimmune rheumatic diseases. Over 3,000 HSCT procedures for rheumatic and nonrheumatic severe autoimmune diseases have been performed worldwide.

Read more

Hematopoietic Stem Cells

Stem cells serve as the source of all the other specialized cells in the body, both when it forms during embryogenesis and when it replaces cells that have been lost to aging, injury or disease.

Read more

Hope for the Future in the Umbilical Cord

Gunnar Bartsch, Stabsstelle Öffentlichkeitsarbeit

Umbilical cord blood has a great potential to heal many diseases. A new research cooperation examines how to grow as many stem cells as possible that are responsible for this effect. Initiator and spokesman of this cooperation is the Würzburg stem cell researcher Albrecht Müller. The Federal Government is funding the project with 1.2 million Euros...

Read more

How Long Can Cord Blood Be Stored?

Over the decades since, we have demonstrated efficient cell recovery at 5 years (5), 10 years (6), 15 years (7), and most recently 23.5 years (8) after the cells were frozen in cryopreserved form. The accuracy of these tests rests on the fact that we have had continuous custody of these cells, and we have performed their post-thaw analysis with the same tests as their pre-freeze measurements. 

Read more

Improved survival in pediatric umbilical cord transplants for hematologic cancers

A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multiyear study published in the New England Journal of Medicine (2014; 371:1685-1694).

 

The research, led by John Wagner Jr, MD, director of the Pediatric Blood and Marrow Transplantation program at the University of Minnesota and a researcher in the Masonic Cancer Center, University of Minnesota in Minneapolis-St. Paul, compared outcomes in children with acute leukemia and myelodysplastic syndrome who received transplants of either one or two units of partially matched cord blood.

Read more

Innovation is the talk of the town

Our decision-makers must seize the opportunity, optimize our first-mover advantage and our national interests, and support Canada’s leadership. Stable, long-term funding for stem cell research and regenerative medicine should be our number-one proof point of Canada’s commitment to science.

 

Read more

Insight: Stem cell therapy poised to come in from the cold

(Reuters) - A rogue surgeon injects stem cells from a fetus into a sick man's brain. The cells morph and form body parts. When the man dies, the pathologist finds cartilage, skin and bone clumped in his brain.

The scene is not from a horror movie; it happened to Max Truex, a former Olympic runner who suffered from Parkinson's disease. The case sent a chill through the scientific community when it came to light 15 years ago and typifies some of the hurdles researchers have faced while trying to bring stem cell therapies to the market.

Read more

Lifetime Probability of Needing a Stem Cell Transplant is Much Higher Than Previously Reported, Data Shows

BROOKEVILLE, Md.--(BUSINESS WIRE)--New data published in the March issue of Biology of Blood and Marrow Transplantation indicate the probability of an individual in the U.S. needing a stem cell transplant, using either one's own stem cells or those from a donor, is much higher than previously stated. This new research says that as many as 1 in 200 people will receive a stem cell transplant during their lifetime, based on current therapeutic...

Read more

Maia's Cord Blood Miracle

One of twin girls, Maia Friedlander suffered oxygen deprivation at birth, which left her drastically developmentally delayed. Despite three years of intensive therapy, her progress was inconsistent and slow. Luckily, her family had banked Maia's cord blood with CordBank at birth.

Read more

Medipost wins patent on stem cell culture fluids preventing hair loss

Medipost said Wednesday that it has acquired a domestic patent on stem cell culture fluids that prevent hair loss. This technology exposes cord blood-derived stem cells to an artificially created hair regression environment to produce a culture solution capable of delivering pharmacological effects such as hair loss prevention.

Read more